Aminoglycoside ototoxicity susceptibility in cystic fibrosis.
Mulrennan
S A
SA
Helm
J
J
Thomas
R Bright
RB
Dodd
M
M
Jones
A
A
Webb
K
K
D000617:Aminoglycosides / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003550:Cystic Fibrosis / Q000235:genetics*; D004272:DNA, Mitochondrial / Q000235:genetics*; D005260:Female; D006316:Hearing Loss, High-Frequency / Q000139:chemically induced*; D006801:Humans; D009154:Mutation / Q000235:genetics; D011552:Pseudomonas Infections / Q000188:drug therapy; D055815:Young Adult
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004272:DNA, Mitochondrial